Edwards Lifesciences (EW) Liabilities from Discontinued Operations (2023 - 2025)

Edwards Lifesciences' Liabilities from Discontinued Operations history runs 3 years deep, the most recent figure standing at 2300000.0 for Q3 2025.

• In Q3 2025, Liabilities from Discontinued Operations rose 27.78% year-over-year to 2300000.0; the TTM figure through Sep 2025 stood at 2300000.0 (up 27.78% YoY), while the FY2024 annual figure was 2000000.0, down 92.03% from the prior year.
• Liabilities from Discontinued Operations was 2300000.0 for Q3 2025 at Edwards Lifesciences, roughly flat from 2300000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 107200000.0 in Q2 2024 to a low of 1800000.0 in Q3 2024.
• Historically, Liabilities from Discontinued Operations has averaged 20428571.43 across 3 years, with a median of 2300000.0 in 2025.
• Biggest YoY gain for Liabilities from Discontinued Operations was 27.78% in 2025; the steepest drop was 97.85% in 2025.
• A 3-year view of Liabilities from Discontinued Operations shows it stood at 25100000.0 in 2023, then sank by 92.03% to 2000000.0 in 2024, then increased by 15.0% to 2300000.0 in 2025.
• The last three Liabilities from Discontinued Operations figures came in at 2300000.0 (Q3 2025), 2300000.0 (Q2 2025), and 2300000.0 (Q1 2025), per Business Quant data.